Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Clinigen Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Clinigen Group Plc, Medical Devices Deals, 2011 to YTD 2017 11
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Clinigen Acquires Rights to Totect from Biocodex USA 14
Clinigen Group Acquires Ethyol from AstraZeneca 15
Clinigen Acquires Savene, Oncology Support Therapy, From SpePharm 16
Clinigen Acquires Cardioxane, Oncology Support Therapy, From Novartis For US$33 Million 17
Partnerships 18
Clinigen Enters into Agreement with Shionogi 18
Clinigen Enters into Distribution Agreement with Romark Labs 19
Clinigen Enters into Distribution Agreement with Mitsubishi Tanabe Pharma 20
Clinigen Group Enters into Distribution Agreement with BioQ Pharma 21
Clinigen Group Partners with Horizon Pharma 22
Cumberland Pharma Enters into Marketing Agreement with Clinigen for Ethyol 23
Cumberland Pharma Enters into Agreement with Clinigen 24
Link Healthcare Enters Co-Marketing Agreement with Sigma-Tau 25
Link Healthcare Enters Into Agreement With Sanochemia Pharmazeutika For Secrelux 26
EirGen Pharma Enters into Agreement with Equity Pharma 27
Licensing Agreements 28
Cumberland Pharma Enters into Licensing Agreement with Clinigen Group 28
Clinigen Extends Licensing Agreement with Hospira for Foscavir 29
Clinigen Enters Into Licensing Agreement With Theravance For Vibativ 30
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 32
NobelPharma Enters Into Licensing Agreement With Clinigen For Foscavir 33
Clinigen Enters Into Licensing Agreement With Hospira For Foscavir 34
Link Healthcare Enters into Licensing Agreement with Salix Pharma for Relistor 35
Equity Offering 36
Clinigen Completes IPO For US$16 Million 36
Acquisition 38
Clinigen to Acquire Quantum Pharma for USD199 Million 38
Clinigen Group Acquires Link Healthcare for USD155.2 Million 39
Clinigen Group Acquires Idis Group for USD338 Million 41
Link Healthcare Acquires Equity Pharma Holdings, Pharma And Medical Technology Company 43
Clinigen Group Plc – Key Competitors 44
Clinigen Group Plc – Key Employees 45
Clinigen Group Plc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 48
Financial Announcements 48
Sep 28, 2017: Clinigen Group: Full Year Results for the Year Ended 30 June 2017 48
Mar 15, 2017: Clinigen Group: Strong H1 Performance with Adjusted EPS up 31% 49
Jan 25, 2017: Clinigen Group HY trading update: strong H1 performance with gross profit up 34% 56
Sep 28, 2016: Clinigen Group: Transformational Year Delivers 25% Growth In Adjusted EPS 58
Jul 20, 2016: Strong second half performance completes transformational year for Clinigen 67
Mar 02, 2016: Clinigen Group Announces Continued Strong Growth With Eps Up 21% 69
Mar 02, 2016: Continued Strong Growth With EPS Up 21% 75
Jan 19, 2016: Clinigen Group announces Half year trading update-2016 76
Corporate Communications 77
Nov 01, 2017: Clinigen Group: Board changes 77
Sep 28, 2016: Shaun Chilton to take over as Chief Executive Officer 79
Other Significant Developments 80
Jul 18, 2017: Clinigen Group: Year End Trading Update 80
Mar 30, 2016: Clinigen Group has become a full member of the European Alliance for Access to Safe Medicines and Alliance for Safe Online Pharmacy in the EU 82
Appendix 83
Methodology 83
About GlobalData 83
Contact Us 83
Disclaimer 83
Clinigen Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Clinigen Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Clinigen Group Plc, Deals By Therapy Area, 2011 to YTD 2017 9
Clinigen Group Plc, Medical Devices Deals, 2011 to YTD 2017 11
Clinigen Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Clinigen Acquires Rights to Totect from Biocodex USA 14
Clinigen Group Acquires Ethyol from AstraZeneca 15
Clinigen Acquires Savene, Oncology Support Therapy, From SpePharm 16
Clinigen Acquires Cardioxane, Oncology Support Therapy, From Novartis For US$33 Million 17
Clinigen Enters into Agreement with Shionogi 18
Clinigen Enters into Distribution Agreement with Romark Labs 19
Clinigen Enters into Distribution Agreement with Mitsubishi Tanabe Pharma 20
Clinigen Group Enters into Distribution Agreement with BioQ Pharma 21
Clinigen Group Partners with Horizon Pharma 22
Cumberland Pharma Enters into Marketing Agreement with Clinigen for Ethyol 23
Cumberland Pharma Enters into Agreement with Clinigen 24
Link Healthcare Enters Co-Marketing Agreement with Sigma-Tau 25
Link Healthcare Enters Into Agreement With Sanochemia Pharmazeutika For Secrelux 26
EirGen Pharma Enters into Agreement with Equity Pharma 27
Cumberland Pharma Enters into Licensing Agreement with Clinigen Group 28
Clinigen Extends Licensing Agreement with Hospira for Foscavir 29
Clinigen Enters Into Licensing Agreement With Theravance For Vibativ 30
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 32
NobelPharma Enters Into Licensing Agreement With Clinigen For Foscavir 33
Clinigen Enters Into Licensing Agreement With Hospira For Foscavir 34
Link Healthcare Enters into Licensing Agreement with Salix Pharma for Relistor 35
Clinigen Completes IPO For US$16 Million 36
Clinigen to Acquire Quantum Pharma for USD199 Million 38
Clinigen Group Acquires Link Healthcare for USD155.2 Million 39
Clinigen Group Acquires Idis Group for USD338 Million 41
Link Healthcare Acquires Equity Pharma Holdings, Pharma And Medical Technology Company 43
Clinigen Group Plc, Key Competitors 44
Clinigen Group Plc, Key Employees 45
Clinigen Group Plc, Subsidiaries 46